Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: J Vasc Surg. 2024 Jan 13;79(5):1151–1162.e3. doi: 10.1016/j.jvs.2024.01.014

Table 1.

Baseline Characteristics by Index Thrombectomy Procedure

Preoperative variables Index Percutaneous Thrombectomy (n=7,335) Index Open Thrombectomy (n=16,460) p-value
Demographics
Age, years 72.2(0.2) 72.6(0.2) .002
Female sex 49.1(46.5–51.6) 50.9(49.3–52.6) .23
Race/ethnicity* .97
 White 79.5(77.2–81.6) 79.1(77.6–80.6)
 Black 10.5(9–12.3) 10.8(9.8–12)
 Hispanic 6.8(5.5–8.4) 6.6(5.7–7.6)
 Asian or Pacific Islander 1(0.6–1.7) 1.2(0.9–1.7)
 American Indian or Alaska Native 0.1(0–0.6) 0.2(0.1–0.4)
 other 2(1.4–2.9) 2(1.6–2.6)
Hospital Region .0003
 Northeast 14.8(12.9–17) 20.2(18.4–22.2)
 Midwest 24.6(22.1–27.3) 24.1(22.2–26.2)
 South 42.4(39.4–45.4) 38(35.8–40.3)
 West 18.2(16–20.7) 17.6(16–19.4)
Bed Size° .40
 Small 14.4(12.5–16.5) 13.3(11.9–14.9)
 Medium 27.5(24.9–30.2) 26.4(24.5–28.4)
 Large 58.1(55.2–61.1) 60.3(58–62.5)
Hospital Type .001
 Rural 3.1(2.3–41) 3.3(2.6–4)
 Urban nonteaching 19.8(17.5–22.2) 15.2(13.8–16.8)
 Urban teaching 77.2(74.6–79.5) 81.5(79.8–83.1)
Insurance type .08
 Medicare 67.8(65.3–70.1) 71(69.4–72.6)
 Medicaid 8.4(7.1–9.9) 8.1(7.2–9.1)
 Private 18.5(16.6–20.6) 15.6(14.4–16.9)
 Self-pay 2.4(1.7–3.3) 2.8(2.3–3.5)
 Other** 2.9(2.2–4) 2.4(1.9–3)
Income quartile⧺ .66
 quartile 1 31.1(28.6–33.6) 29.8(28.1–31.6)
 quartile 2 28.5(26.2–30.9) 28(26.5–29.7)
 quartile 3 22.2(20.1–24.5) 23.7(22.3–25.2)
 quartile 4 18.2(16.2–20.4) 18.4(17–19.9)
Comorbid conditions
Peripheral arterial disease 70.8(68.4–73) 68.6(66.9–70.2) .13
Prior peripheral vascular intervention 6.4(5.3–7.9) 4.8(4.2–5.6) .021
Lower extremity aneurysm 4.0(3.1–5.2) 2.7(2.3–3.4) .024
Atrial fibrillation 28.7(26.4–31.1) 36.5(34.9–38.2) <0.0001
Congestive heart failure 25.8(23.6–28.1) 29.6(28–31.1) .007
Hypertension 79.1(76.9–81.1) 80.3(78.8–81.6) .35
Smoker 51.5(48.8–54.1) 53.2(51.5–54.9) .27
Chronic lung disease 23.7(21.6–26) 28(26.5–29.6) .002
Renal failure 21.4(19.3–23.6) 21.1(19.8–22.6) .84
Diabetes 30.8(28.5–33.3) 29.5(28–31.1) .38
Hypercoagulable 3.4(2.6–4.5) 4.1(3.5–4.8) .25
Preoperative Anticoagulation 22.6(20.5–24.7 23.9(22.4–25.4) .32
Cancer 6.7(5.6–8.1) 6.3(5.6–7.2) .60
Risk Analysis Index 29.5(0.2) 30.1(0.2) .04
Operative details
Multilevel 34.8(32.3–37.3) 36.3(34.6–38) .32
Bilateral Treated Levels 13.0(11.3–14.8) 14.1(13.0–15.5) .27
 Aortoiliac 27.1(24.8–29.4) 25.5(24–27) .25
 Femoropopliteal 86.2(84.3–87.8) 88.8(87.7–89.8) .009
 Tibial 23.2(21.1–25.5) 25.8(24.3–27.3) .07
Fasciotomy 4.8(3.8–6) 6.9(6–7.8) .006
Compartment Syndrome 3.9(3.01–5.0) 5.5(4.8–6.4) .02
Weekend admission 23.9(21.7–26.1) 24.4(23–26) .67